HOME >> MEDICINE >> NEWS
The Burroughs Wellcome Fund awards $8 million to infectious disease investigators

RESEARCH TRIANGLE PARK, N.C. -- When the 16 recipients of the Burroughs Wellcome Fund's Investigators in Pathogenesis of Infectious Disease award were notified that they had received the award, there was more good news. The award amount had increased to $500,000 over a five-year period from $400,000.

The Investigators in Pathogenesis of Infectious Disease awards are made to encourage aggressive, multidisciplinary approaches to investigating pathogenesis. BWF launched the program in 2002 and has made 58 awards for an investment of approximately $24.8 million in the careers of investigators who are working on understanding the interaction between the human host and the infectious agentbacterial, viral, fungal, or parasitic.

All awardees hold tenure-track faculty positions and must be nominated by degree-granting institutions in the United States or Canada.

"The constant threat of infectious disease is of global concern, BWF President Dr. Enriqueta Bond said. "Understanding the underlying principles of how the microbial world interacts with the human host is of paramount importance. We are pleased to play a role in the expansion of knowledge in this important scientific field.

Following are the 2007 award recipients, along with their institutions and research projects:

Benjamin K. Chen, M.D., Ph.D.
Mount Sinai School of Medicine
Dissemination of HIV through virological synapses

Andrew Darwin, Ph.D.
New York University School of Medicine
Mechanisms of Pseudomonas aeruginosa tolerance to secretin-induced stress during host infection

Michael R. Farzan, Ph.D.
Harvard Medical School
Parallel identification of obligate viral receptors

Britt Glaunsinger, Ph.D.
University of California-Berkeley
Global modulation of cellular gene expression by an oncogenic human herpesvirus

Karen J. Guillemin, Ph.D.
University of Oregon
Reg
'"/>

Contact: Russ Campbell
news@bwfund.org
919-991-5119
Burroughs Wellcome Fund
4-Jun-2007


Page: 1 2

Related medicine news :

1. Wellcome brain insights
2. University hospitals wins multiple national IT awards for electronic patient data bank
3. CIRM awards $3.79 million to Burnham Institute
4. Gerontological Society of America awards new Hartford Doctoral Fellowships
5. AACR awards minority and other underrepresented scientists
6. FNSNA awards $25,000 grant to Rutgers College of Nursing
7. International and American Associations for Dental Research present awards and fellowships
8. JDRF awards Emory $2.5 million to develop islet transplant technology
9. NIH awards $1 million to Temple University Hospital for neurological treatment studies
10. NHLBI awards 12 Womens Health Initiative contracts
11. The Gerontological Society of America awards new Hartford Doctoral Fellowships

Post Your Comments:
(Date:5/22/2015)... 2015 Carnegie Science Center ... a new partnership to develop BodyTech, a dynamic, three-pronged ... initiative includes a new exhibit at the Science Center ... and a new traveling science show, Anatomy Adventure, which ... , Designed to explore a wide range of ...
(Date:5/22/2015)... Boston, Massachusetts (PRWEB) May 22, 2015 ... conditions is a difficult process. Historically providers have ... efforts by payers. Starting in 2015, Medicare has ... care coordination activities. Thanks to the launch of ... technology, providers and health systems using the platform ...
(Date:5/22/2015)... Memorial Day weekend is typically considered the beginning of ... tips to help promote safe travel. , According to estimates ... fatalities this Memorial Day weekend. Amica is sharing the following ... , , Always wear a seatbelt: ... whether they’re driving or riding along as a passenger. Seatbelts ...
(Date:5/22/2015)... Seattle, WA (PRWEB) May 22, 2015 According ... adults of all generations are equally as likely to worry ... (72% Millennials, 75% Gen X, 77% Boomers, 69% Silent Generation), ... (45%) agree they are scared of aging, particularly Millennials (47%), ... online by Harris Poll in April, 2015 among more than ...
(Date:5/22/2015)... Power Systems is proud to announce the ... season. Drobeck is in his second year of racing in ... the Missoula Fire Department in Missoula, MT. He entered the ... During his career, he has had 15 1st Place finishes. ... 10 finishes in all seven of his 2014 races, including ...
Breaking Medicine News(10 mins):Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 2Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 3Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 4Health News:Oculus Health Care Coordination Platform Officially Launched 2Health News:Oculus Health Care Coordination Platform Officially Launched 3Health News:Oculus Health Care Coordination Platform Officially Launched 4Health News:Amica Has 4 Road Safety Tips for Memorial Day Weekend 2Health News:New Study Reveals America’s Fear of Aging 2Health News:New Study Reveals America’s Fear of Aging 3
(Date:5/22/2015)... May 22, 2015  The U.S. Food and ... -- the first biosimilar product approved in ... toward growth in the contract manufacturing organization (CMO) ... industry is geared to the production of small-molecular ... biopharmaceutical products. The healthcare market research publisher,s report, ...
(Date:5/22/2015)... YORK and KING OF PRUSSIA, Pa. ... Foundation (NHF) has awarded CSL Behring its ... and unwavering commitment to advancing science and improving the care ... Paul Perreault , CEO and Managing Director, CSL Limited, ... York City on May 21. "The ...
(Date:5/22/2015)... ROCKVILLE, Md. , May 22, 2015 /PRNewswire/ ... "RegeneRx") today announced a peer-reviewed publication of the ... study evaluating RGN-259 (RegeneRx,s preservative-free eye drops) for ... Inc.,s controlled adverse environment (CAE ® ) model.  ... and the results, which were previously disseminated by ...
Breaking Medicine Technology:Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 4National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 2National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 3National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 4Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 2Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 3Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 4
Cached News: